Harmony Biosciences Holdings, Inc.

SEC insider activity covers quarterly filings through June 30, 2026. Later filings are not included. Reported roles do not establish current employment or current holdings. SEC filing documents, sections and filing-text search cover filings dated January 1, 2000 onward. Earlier filings are deferred until after launch.

HRMY

organization

SIC: 2834

SEC Insider

$568.9M

488 transactions

Summary

Harmony Biosciences Holdings, Inc. (HRMY) is an organization.

Recent Insider Transactions

As filed, including amendments; not net cash flow or current holdings. Joint reports count once. Totals cover known values only.

Buys: $12.5MSales: $534.9M30 insiders

Date	Insider	Type	Value
2026-05-01	Budur Kumar(CHIEF MEDICAL OFFICER)	F	$283K
2026-01-25	Dayno Jeffrey M.(PRESIDENT, CEO)	F	$208K
2026-01-26	Kapadia Sandip(CHIEF FINANCIAL OFFICER)	Sell	$139K
2026-04-07	Zaeske Adam H.(CHIEF COMMERCIAL OFFICER)	F	$88K
2026-05-14	Germano Geno J	A	$0
2026-05-14	Graf R. Mark	A	$0
2026-05-14	Sender Gary	A	$0
2026-05-14	Szyper Linda M	A	$0
2026-05-14	Sabater Juan A.	A	$0
2026-05-14	Philip Ron M	A	$0
2026-05-01	Budur Kumar(CHIEF MEDICAL OFFICER)	M	$0
2026-05-01	Budur Kumar(CHIEF MEDICAL OFFICER)	M	$0
2026-04-14	Reicin Glenn(CHIEF FINANCIAL OFFICER)	A	$0
2026-04-07	Zaeske Adam H.(CHIEF COMMERCIAL OFFICER)	M	$0
2026-04-07	Zaeske Adam H.(CHIEF COMMERCIAL OFFICER)	M	$0
2026-04-02	Ignelzi Troy A.	A	$0
2026-04-02	Anastasiou Peter(CHIEF OPERATING OFFICER)	A	$0
2026-01-25	Dayno Jeffrey M.(PRESIDENT, CEO)	M	$0
2026-01-25	Dayno Jeffrey M.(PRESIDENT, CEO)	M	$0
2026-01-25	Kapadia Sandip(CHIEF FINANCIAL OFFICER)	M	$0

SEC filings: SEC EDGAR

Activity data: SEC EDGAR

Harmony Biosciences Holdings, Inc. — Contributions, Lobbying & Contracts | Poliscope